A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
Clinical trial NCT07569029 · RECRUITING
Trial details
- NCT number
- NCT07569029
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-15
- Primary completion
- 2027-08-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.